May 14 (Reuters)-
Stemcell Institute
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.48 2.09 3.00
(+18.6 pct) (+17.4 pct) (+20.9 pct)
Operating 413 mln 297 mln 600 mln
(+39.1 pct) (+31.1 pct) (+45.0 pct)
Recurring 417 mln 300 mln 600 mln
(+38.9 pct) (+41.3 pct) (+43.8 pct)
Net 310 mln 198 mln 500 mln
(+57.0 pct) (+48.1 pct) (+60.8 pct)
EPS 30.35 yen 19.33 yen 48.80 yen
Ann Div NIL NIL 25.00 yen
-Q2 Div NIL NIL 25.00 yen
-Q4 Div NIL NIL NIL
NOTE - Stemcell Institute.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7096.T